Results 291 to 300 of about 1,664,796 (355)

Building a Framework for Sexual and Reproductive Health Care in the Rheumatology Context: Content and Approaches

Arthritis Care &Research, EarlyView.
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley   +1 more source

The Physician‐Scientist Pipeline for Pediatric Rheumatology – Current Landscape and Future Perspectives.

Arthritis Care &Research, Accepted Article.
Over the past 50 years, the science of pediatric rheumatology has grown exponentially due to an expansion in the understanding of complex rheumatic conditions and a surge in novel targeted therapeutics. Physician‐scientists in the field of pediatric rheumatology have played major roles in these advancements that have improved the care of children ...
Ekemini A. Ogbu, Linda T. Hiraki, Mara L. Becker   +2 more
wiley   +1 more source

Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs

H Takahashi
openalex   +2 more sources

Topical Minoxidil and Low-Dose Oral Minoxidil in Onychodystrophy: A Proposed Treatment Algorithm. [PDF]

J Cosmet Dermatol
Gupta AK, Talukder M, Lipner SR.
europepmc   +1 more source

Exome Sequencing Identifies Multiple Genetic Diagnoses in Children with Syndromic Growth Disorders

Alexander Augusto de Lima Jorge
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[Growth disorders].

Ceskoslovenska pediatrie, 1992
In growth disorders it is important to consider carefully all causes which may lead to growth retardation. Therefore possible factors and diagnostic possibilities are listed. The importance of the prognosis of the affected child is emphasized.
  +6 more sources

Therapy of growth disorders

Current Opinion in Endocrinology, Diabetes & Obesity, 2011
We review recent developments in the therapy of growth disorders, focusing mainly on recent developments in the field of growth hormone (GH) therapy.Review of current practice reveals wide variation in the approach to short stature and the institution of GH therapy.
Omar, Ali, David, Wyatt
openaire   +2 more sources

Imprinted disorders and growth

Annales d'Endocrinologie, 2017
Fetal growth is a complex process. Its restriction is associated with morbidity and long-term metabolic consequences. Imprinted genes have a critical role in mammalian fetal growth. Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS) are two imprinting disorders with opposite fetal growth disturbance.
Giabicani, Eloïse, Brioude, Frédéric, Le Bouc, Yves, Netchine, Irène   +3 more
openaire   +3 more sources

Pharmacogenomics Related to Growth Disorders

Hormone Research in Paediatrics, 2013
Growth disorders resulting in short stature are caused by a wide range of underlying pathophysiological processes. To improve height many of these conditions are treated with recombinant human growth hormone (rhGH). However, substantial inter-individual variability in growth response both in the short and long-term is recognised.
Stevens, A., De Leonibus, C., Whatmore, A., Hanson, D., Murray, P., Chatelain, P., Westwood, M., Clayton, P.   +7 more
openaire   +2 more sources

Growth Disorders in Children

Pediatric Clinics of North America, 1979
The assessment of growth patterns in children has become an important parameter to consider in the detection of endocrine abnormalities. Two such disorders, short and tall stature, are discussed, and emphasis is placed on their etiology, clinical manifestations, diagnosis, and treatment.
openaire   +2 more sources